Trial Outcomes & Findings for Imaging of Peri-operative (periOP) Lung Injury (NCT NCT02978885)

NCT ID: NCT02978885

Last Updated: 2021-09-14

Results Overview

To determine if peri-operative lung injury can be detected with in vivo imaging in patients with COPD

Recruitment status

TERMINATED

Study phase

PHASE2

Target enrollment

1 participants

Primary outcome timeframe

Up to 1 week from initial scan

Results posted on

2021-09-14

Participant Flow

Participant milestones

Participant milestones
Measure
Normal Preoperative Lung Function
Patients with normal lung function undergoing Whipple procedures or other major surgeries will receive an injection of AxV-128 labeled with 99mTc followed by SPECT-CT (AxV-128/Tc SPECT-CT imaging). SPECT-CT imaging: Injection of AxV-128 labeled with 99mTc followed by SPECT CT AxV-128/Tc: Injection of AxV-128 labeled with 99mTc Whipple procedure: A Whipple procedure - also known as a pancreaticoduodenectomy - is a complex operation to remove the head of the pancreas, the first part of the small intestine (duodenum), the gallbladder and the bile duct. The Whipple procedure is used to treat tumors and other disorders of the pancreas, intestine and bile duct. It is the most often used surgery to treat pancreatic cancer that's confined to the head of the pancreas. After performing the Whipple procedure, your surgeon reconnects the remaining organs to allow you to digest food normally after surgery. Standard of care. Major surgery: Additional surgical procedure(s) that is clinically indicated. Standard of care.
Preoperative COPD
Patients with moderate COPD undergoing Whipple procedures or other major surgeries will receive an injection of AxV-128 labeled with 99mTc followed by SPECT-CT (AxV-128/Tc SPECT-CT imaging). SPECT-CT imaging: Injection of AxV-128 labeled with 99mTc followed by SPECT CT AxV-128/Tc: Injection of AxV-128 labeled with 99mTc Whipple procedure: A Whipple procedure - also known as a pancreaticoduodenectomy - is a complex operation to remove the head of the pancreas, the first part of the small intestine (duodenum), the gallbladder and the bile duct. The Whipple procedure is used to treat tumors and other disorders of the pancreas, intestine and bile duct. It is the most often used surgery to treat pancreatic cancer that's confined to the head of the pancreas. After performing the Whipple procedure, your surgeon reconnects the remaining organs to allow you to digest food normally after surgery. Standard of care. Major surgery: Additional surgical procedure(s) that is clinically indicated. Standard of care.
Overall Study
STARTED
0
1
Overall Study
COMPLETED
0
1
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Imaging of Peri-operative (periOP) Lung Injury

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: Up to 1 week from initial scan

Population: Study terminated due to poor enrollment. Data was not analyzed or disclosed due to subject confidentiality being an issue (n=1).

To determine if peri-operative lung injury can be detected with in vivo imaging in patients with COPD

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: Up to 1 week from initial scan

Population: Study terminated due to poor enrollment. Data was not analyzed or disclosed due to subject confidentiality being an issue (n=1).

To determine if peri-operative lung injury can be detected with in vivo imaging in patients with COPD

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: Up to 1 week from initial scan

Population: Study terminated due to poor enrollment. Data was not analyzed or disclosed due to subject confidentiality being an issue (n=1).

To determine if peri-operative lung injury can be detected with in vivo imaging in patients with COPD

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Up to 1 week from initial scan

Population: Study terminated due to poor enrollment. Data was not analyzed or disclosed due to subject confidentiality being an issue (n=1).

To determine if peri-operative lung injury can be detected with in vivo imaging in patients with COPD

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Up to 1 week from initial scan

Population: Study terminated due to poor enrollment. Data was not analyzed or disclosed due to subject confidentiality being an issue (n=1).

To determine if peri-operative lung injury can be detected with in vivo imaging in patients with COPD

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Up to 1 week from initial scan

Population: Study terminated due to poor enrollment. Data was not analyzed or disclosed due to subject confidentiality being an issue (n=1).

To determine if peri-operative lung injury can be detected with in vivo imaging in patients with COPD

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Up to 1 week from initial scan

Population: Study terminated due to poor enrollment. Data was not analyzed or disclosed due to subject confidentiality being an issue (n=1).

To determine if peri-operative lung injury can be detected with in vivo imaging in patients with COPD

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Up to 1 week from initial scan

Population: Study terminated due to poor enrollment. Data was not analyzed or disclosed due to subject confidentiality being an issue (n=1).

To determine if peri-operative lung injury can be detected with in vivo imaging in patients with COPD

Outcome measures

Outcome data not reported

Adverse Events

Normal Preoperative Lung Function

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Preoperative COPD

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Gebhard Wagener, MD

Columbia University

Phone: 212-305-6494

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place